Form 4: OPKO Health Director Yu Alice Lin-Tsing Acquires 30,000 Stock Options

Director Yu Alice Lin-Tsing acquired 30,000 stock options in OPKO Health, Inc. on April 23, 2025.

Summary

• On April 23, 2025, Yu Alice Lin-Tsing, a director of OPKO Health, Inc., acquired 30,000 stock options.
• The options have an exercise price of $1.47.
• The options become exercisable on April 23, 2026, and expire on April 22, 2035.
• Following the transaction, Yu Alice Lin-Tsing directly owns 30,000 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock option acquisition by a director. While option grants can be seen as a positive incentive, this filing itself doesn't provide strong positive or negative signals.

Positives

• The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership of securities. It's common for directors and officers of publicly traded companies to receive stock options as part of their compensation.

Stakeholder Impact

• The acquisition of stock options by a director may have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

OPKO Health, Director, Stock Options, Form 4, Beneficial Ownership, Yu Alice Lin-Tsing